非小细胞肺癌患者的预后因素分析

被引：9

作者：

康艳虹

马为

机构：

[1] 广州医科大学附属广州市第一人民医院呼吸内科

来源：

广东医学 | 2014年 / 35卷 / 04期

关键词：

非小细胞肺癌; 预后因素; 生存率;

D O I：

10.13820/j.cnki.gdyx.2014.04.016

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

目的分析非小细胞肺癌（NSCLC）患者的预后因素。方法对115例NSCLC患者进行生存分析。结果 115例NSCLC患者的1、2、3年生存率分别为38%、26%、20%。总的中位生存期为8.0个月,Cox分析显示性别、临床分期是影响NSCLC患者预后的独立因素。其中90例ⅢbⅣ期NSCLC患者的1、2、3年生存率分别为26%、13%、3%,总的中位生存期为5.0个月,Cox分析显示远处转移与否、治疗方式是影响ⅢbⅣ期NSCLC患者预后的独立因素。积极治疗者获得较长生存期（中位生存期9.0个月）,长于对症支持治疗者（中位生存期3.0个月）,差异有统计学意义（P=0.003）。结论性别、临床分期、远处转移与否是影响NSCLC患者预后的重要因素,早发现、早治疗是延长NSCLC患者生存期的重要措施。

引用

页码：524 / 527

页数：4

共 13 条

[1]

The Surgical Management of Stage I and Stage II Lung Cancer [J].

Gorenstein, Lyall A. ;

Sonett, Joshua R. .

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (04) :701-+

[2]

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial.[J].Gail E. Darling;Mark S. Allen;Paul A. Decker;Karla Ballman;Richard A. Malthaner;Richard I. Inculet;David R. Jones;Robert J. McKenna;Rodney J. Landreneau;Valerie W. Rusch;Joe B. Putnam.The Journal of Thoracic and Cardiovascular Surgery.2011, 3

[3]

Survival Differences by Gender for Resected Non-small Cell Lung Cancer A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study [J].

Sakurai, Hiroyuki ;

Asamura, Hisao ;

Goya, Tomoyuki ;

Eguchi, Kenji ;

Nakanishi, Yoichi ;

Sawabata, Noriyoshi ;

Okumura, Meinoshin ;

Miyaoka, Etsuo ;

Fujii, Yoshitaka .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) :1594-1601

[4]

Lung Cancer Histology, Stage, Treatment, and Survival in American Indians and Alaska Natives and Whites [J].

Fesinmeyer, Megan Dann ;

Goulart, Bernardo ;

Blough, David K. ;

Buchwald, Dedra ;

Ramsey, Scott D. .

CANCER, 2010, 116 (20) :4810-4816

[5]

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J].

Ferlay, Jacques ;

Shin, Hai-Rim ;

Bray, Freddie ;

Forman, David ;

Mathers, Colin ;

Parkin, Donald Maxwell .

INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) :2893-2917

[6]

Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer.[J].Eun Jung Jung;Jong Hoo Lee;Kyeongman Jeon;Won-Jung Koh;Gee Young Suh;Man Pyo Chung;Hojoong Kim;O Jung Kwon;Young Mog Shim;Sang-Won Um.Lung Cancer.2010, 2

[7]

Surgical treatment of oligometastatic non-small cell lung cancer [J].

Pfannschmidt, Joachim ;

Dienemann, Hendrik .

LUNG CANCER, 2010, 69 (03) :251-258

[8]

A Pessimistic Explanatory Style Is Prognostic for Poor Lung Cancer Survival [J].

Novotny, Paul ;

Colligan, Robert C. ;

Szydlo, Daniel W. ;

Clark, Matthew M. ;

Rausch, Sarah ;

Wampfler, Jason ;

Sloan, Jeff A. ;

Yang, Ping .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) :326-332

[9]

Five‐year lung cancer survival.[J].TinaWang;Rebecca A.Nelson;AliciaBogardus;Frederic W.Grannis.Cancer.2010, 6

[10]

Long-term survivors of more than 5 years in advanced non-small cell lung cancer.[J].Kyoichi Kaira;Toshiaki Takahashi;Haruyasu Murakami;Asuka Tsuya;Yukiko Nakamura;Tateaki Naito;Masahiro Endo;Nobuyuki Yamamoto.Lung Cancer.2009, 1

← 1 2 →